Related Experiment Video
Updated: Jul 15, 2026
10:55
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
[Diagnostic difficulties in polymyositis]
Dominik Majewski1, Mariusz Puszczewicz, Aleksandra Tuchocka-Piotrowska
1Katedra i Klinika Reumatologiczno-Rehabilitacyjna i Chorób Wewnetrznych Akademii Medycznej im. K. Marcinkowskiego ul. 28 Czerwca 1956 roku 135/147, 61-545 Poznań.
Annales Academiae Medicae Stetinensis
|May 3, 2007
Summary
Polymyositis, a connective tissue disease, can affect internal organs and cause arthritis, particularly with anti-synthetase syndrome. This case highlights polymyositis with interstitial lung disease and arthritis, suggesting an overlap syndrome.
Area of Science:
- Rheumatology
- Pulmonology
- Immunology
Background:
- Polymyositis is a rare idiopathic inflammatory myopathy characterized by symmetrical muscle weakness.
- Connective tissue diseases like polymyositis can involve multiple organ systems, including the lungs.
- Arthritis is a known comorbidity in polymyositis, especially within the anti-synthetase syndrome spectrum.
Observation:
- A case report details a woman diagnosed with polymyositis and interstitial lung disease.
- The patient also presented with arthritis.
- Serum analysis revealed the presence of anti-cyclic citrullinated peptide antibodies.
Findings:
- The co-occurrence of polymyositis, interstitial lung disease, and arthritis in this patient is notable.
- The presence of anti-cyclic citrullinated peptide antibodies alongside these clinical features is significant.
- These findings support the potential for an overlap syndrome.
Implications:
- This case underscores the importance of considering overlap syndromes in patients with polymyositis and arthritis.
- Identifying specific autoantibodies like anti-CCP antibodies can aid in diagnosing complex cases.
- Early recognition and diagnosis of overlap syndromes are crucial for appropriate management and treatment strategies in polymyositis patients.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:19Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...